Subscribe to RSS
DOI: 10.1055/s-0028-1088211
Utilization of N,N,N′,N′-Tetramethylfluoroformamidinium Hexafluorophosphate (TFFH) in Peptide and Organic Synthesis
Publication History
Publication Date:
16 March 2009 (online)
Biographical Sketches


Abstract
N,N,N′,N′-Tetramethylfluoroformamidinium hexafluorophosphate (TFFH) has been shown to be an excellent peptide-coupling reagent. It is an easily handled, crystalline compound, it has a long shelf life, and it reacts rapidly with carboxylic acids to give the corresponding acid fluorides or mixed anhydrides depending on the reaction conditions. TFFH has been shown to be useful as a peptide-coupling reagent and for the preparation of various carboxylic acid derivatives. Both aspects will be surveyed in this Account.
1 Introduction
2 Formation of Carboxylic Acid Halides
3 General Method for the Synthesis of Fluoroformamidinium Salts
4 Solution and Solid-Phase Peptide Coupling Using TFFH
5 Synthesis of Small Phosphotyrosine-Containing Peptides and Peptide Mimetics Incorporating α-Methylated Amino Acids
6 Synthesis of Lysine Analogues
7 Synthesis of Proline Conformation in Tripeptide Fragments of Bovine Pancreatic Ribonuclease A Containing the Nonnatural Proline Analogue 5,5-Dimethylproline
8 Synthesis of Different Types of Dipeptide Building Units Containing N- or C-Terminal Arginine for the Assembly of Backbone Cyclic Peptides
9 Synthesis of Peptidyl Methylcoumarin Esters as Substrates and Active-Site Titrants for Prohormone Processing
10 Synthesis of Boc-(N-All)Xaa-(N-All)Xaa-OMe
11 Synthesis of Alamethicin F30 and Analogues Using TFFH
11.1 C-Terminal Alamethicin F30-Fullerene C60 and C70 Conjugates
11.2 N-Terminal Alamethicin F30-Fullerene C60 Conjugate
12 Miscellaneous Examples
12.1 Synthesis of Isothiocyanates and Hydrazides
12.2 Conversion of Carboxylic Acids into Anilides and Azides
12.3 Acylation of Alcohols, Thiols, and Dithiocarbamates
12.4 Conversion of Carboxylic Acids into Alcohols and Hydroxamic Acids Using TFFH/PTF
12.5 Preparation of 2-Aminobenzimidazole, 2-Aminobenzoxazole, and 2-Aminobenzothiazole Derivatives
12.6 Formation of Interchain Carboxylic Anhydrides on Self-Assembled Monolayers
12.7 Synthesis of the A1B(A)C Fragment of Everninomicin 13,384-1
12.8 Synthesis of Chiral Polyionic Dendrimers with Complementary Charges
13 Conclusion
Key words
TFFH - amino acid fluorides - solution-phase peptide synthesis - solid-phase peptide synthesis - carboxylic acid derivatives - heterocycles
1 Introduction
Recently, the use of new coupling reagents for peptide synthesis has been reviewed. [¹] The present Account concentrates on the fluoroformamidinium salts which show some advantages over other commonly used coupling reagents.
2 Formation of Carboxylic Acid Halides

Figure 1 Structures of chlorinating reagents
The most obvious method for activating the carboxyl group of an amino acid for amide bond formation at room temperature or below would appear to be via a simple acid chloride. [²] The acid chloride method was first introduced into peptide chemistry by Fischer in 1903. [³] Since then, chlorination of amino acids has been carried out with various chlorinating reagents, such as pivaloyl chloride, [4] phthaloyl dichloride, [5] thionyl chloride, [6] and oxalyl chloride. [7] Thionyl chloride in pyridine was applied to the coupling reactions for this purpose. [7b] Other useful acid halogenating reagents are cyanuric chloride [8] (1) and 2-chloro-4,6-dimethoxy-1,3,5-triazine [9] (CDMT, 2) (Figure [¹] ). Gilon has reported the use of bis(trichloromethyl) carbonate (BTC, 3) as a chlorinating reagent in solid-phase peptide synthesis. [¹0] There is some question as to the nature of the exact intermediates involved in the Gilon process. [¹0b]
Coupling reactions mediated by BTC gave good results for Fmoc-amino acids containing acid-labile side chains. In some solvents, such as N-methyl-2-pyrrolidinone, reaction with BTC gives the chloroiminium ion. Since this leads to racemization, inert solvents such as tetrahydrofuran or dioxane are used in the Gilon reaction. For many years acid chlorides were rarely used and, among peptide practitioners, they long ago gained the reputation of being ‘overactivated’ and therefore prone to numerous side reactions including loss of configuration. [¹¹] However, because of the stability of the 9-fluorenylmethoxycarbonyl (Fmoc) group to the conditions of preparation, Fmoc-amino acid chlorides were shown to be very useful in peptide coupling. Under appropriate conditions such acid chlorides can be used without loss of configuration. Because of their high reactivity, they can be used for highly hindered substrates. One deficiency of these systems is that acid-sensitive side chains, such as those derived from tert-butyl residues, cannot be accommodated. [6c] Acid fluorides, on the other hand, are known to be more stable to hydrolysis than acid chlorides and, in addition, are not subject to the limitation mentioned with regard to tert-butyl-based side-chain protection. Thus, Fmoc-based solid-phase peptide synthesis can be easily carried out via Fmoc-amino acid fluorides. [¹²] [¹³] Cyanuric fluoride (4) (Figure [²] ) is the most commonly used reagent for the conversion of amino acids into the corresponding acid fluorides. [¹³]

Figure 2
Other reagents which can be used are (diethylamino)sulfur trifluoride (DAST), [¹4] and the pyridinium salts FEP (2-fluoro-1-ethylpyridinium tetrafluoroborate, 5) and FEPH (2-fluoro-1-ethylpyridinium hexachloroantimonate, 6) [¹5] (Scheme [¹] ), Mukaiyama reagents modified by substitution of the simple halide counterion for the more solubilizing BF4 - or SbCl6 - counterion. [¹5] [¹6]

Scheme 1
The conversion of acids into acid fluorides with all of these reagents follows a similar process. For example, with cyanuric fluoride (4) the intermediate 7 is involved (Scheme [²] ). The presence of a base was found to be essential for formation of the carboxylic acid fluorides. IR and UV spectroscopic measurements confirm this course of the reaction. [¹6-¹8]

Scheme 2 Synthesis of amino acid fluorides using cyanuric fluoride
Standard methods for the preparation of carboxylic acid fluorides often involve noxious reagents such as various metal fluorides. [¹9] A notable advance was the development of fluoroformamidinium salts. Carpino and El-Faham reported that the air-stable, non-hygroscopic solid N,N,N′,N′-tetramethylfluoroformamidinium hexafluorophosphate (TFFH, 8) acts as a convenient in situ reagent for the formation of amino acid fluorides during peptide synthesis (Scheme [³] ). [²0] TFFH is especially useful for the two amino acids histidine and arginine since the corresponding amino acid fluorides are themselves not stable toward isolation or storage.

Scheme 3 Synthesis of amino acid fluorides using TFFH
Infrared examination shows that, in the presence of N,N-diisopropylethylamine (DIPEA), Fmoc-amino acids are converted into the acid fluorides using TFFH. [²0] In dichloromethane solution at room temperature, an IR absorption characteristic of the carbonyl fluoride moiety (1842 cm-¹) appears after about 3 minutes, with complete conversion into the acid fluoride occurring after 8-15 minutes. For hindered amino acids [e.g., α-aminoisobutyric acid (Aib)], complete conversion may require 1-2 hours. [²0] [²¹] If desired, the acid fluorides may be isolated and purified, making TFFH a benign substitute for the corrosive cyanuric fluoride.
Other analogous reagents have also been synthesized (Figure [³] ). Bis(tetramethylene)fluoroformamidinium hexafluorophosphate (BTFFH, 9) has the advantage over TFFH in that, upon workup, the reaction mixture does not generate toxic byproducts. [²¹] [²²]

Figure 3 Structures of fluorinating reagents
Fluorinating reagents 9, 11, 12, and 13 behave in a similar way to 8 in their ability to provide a route to amino acid fluorides for both solution and solid-phase reactions, [²0] [²¹] whereas 10, being more reactive but more sensitive to moisture, never gives complete conversion into the acid fluoride. Except for 10, all of these reagents can be handled in air in the same way as common onium reagents, [²³] such as N-[(dimethylamino)(1H-1,2,3-triazolo[4,5-b]pyridin-1-yl)methylene]-N-methylmethanaminium hexa-fluorophosphate N-oxide (N-HATU, 14) [²4] and N-[(1H-benzotriazol-1-yl)(dimethylamino)methylene]-N-methylmethanaminium hexafluorophosphate N-oxide (N-HBTU, 15) [²5] (Figure [4] ).

Figure 4
For some amino acids, e.g. Fmoc-Aib-OH, it was found that the use of TFFH alone gave results that were less satisfactory than those obtained with isolated amino acid fluorides. The deficiency was traced to inefficient conversion into the acid fluoride which, under the conditions used (DIPEA, 2 equiv), was accompanied by the corresponding symmetric anhydride and oxazolone. [²¹] [²6] On the other hand, it has now been shown that if a fluoride additive such as benzyltriphenylphosphonium dihydrogen trifluoride (PTF, 16) or hydrogen fluoride-pyridine (17) [²7] (Figure [5] ) is present during the activation step, the latter two products can be avoided and a maximum yield of acid fluoride is obtained. Assembly of the difficult pentapeptide Tyr-Aib-Aib-Phe-Leu-NH2 via TFFH coupling in the presence of PTF (16) gave a product of similar quality to that obtained via the isolated acid fluorides.

Figure 5
More interestingly, conversion of the acid into the acid fluoride was also observed upon treatment with N,N′-dicyclohexylcarbodiimide (DCC, 18), diisopropylcarbodiimide (DIC, 19) (Figure [6] ), N-HATU (14), or N-HBTU (15) in the presence of the additive PTF (16). [²7] [²8]

Figure 6
Because the fluoride additive binds excess hydrogen fluoride as part of the complex dihydrogen trifluoride anion, an accompanying acidic buffering effect might prove to be of value in the case of coupling reactions where loss of configuration at the activated carboxylic acid residue might be important. Such a protective effect was in fact observed in the case of the sensitive histidine derivative Fmoc-His(Trt)-OH upon reaction with proline amide, which with TFFH/DIPEA under ordinary conditions gave the desired dipeptide in good yield with 7.4% stereomutation; in the presence of additive 16, stereomutation dropped to 1.8%. [²7]
Generation of the amino acid fluoride using TFFH (8) is more efficient if PTF (16) is present, as shown by model solid-phase syntheses. [²7] Presumably, this technique can also be used to improve conversion into the isolable acid fluorides. [²8]
3 General Method for the Synthesis of Fluoroformamidinium Salts
Following is a typical procedure for the preparation of fluoroformamidinium salts; [²0] namely, TFFH (8) (Scheme [4] ):
In a two-liter, three-necked round flask equipped with a mechanical stirrer, an addition funnel, and a reflux condenser, oxalyl chloride (70 mL, 0.80 mol) was added in one portion to a solution of 1,1,3,3-tetramethylurea (69.7 g, 0.60 mol) in toluene (1 L) with vigorous stirring. The mixture was heated at 60 ˚C for two hours and then cooled to room temperature. The addition funnel was replaced with a fritted adapter and the supernatant liquid was expelled using a positive pressure of nitrogen. The precipitate was collected and washed with toluene and then with anhydrous diethyl ether. The dichloro salt was collected and dissolved quickly in dichloromethane (1 L) and treated with a saturated solution of potassium hexafluorophosphate (0.6 mol) in water. The reaction mixture was stirred vigorously at room temperature for 10-15 minutes and then the dichloromethane phase was collected and dried (MgSO4). The solvent was removed under reduced pressure to give the chloro salt, TCFH (20). To a solution of 20 (0.5 mol) in anhydrous acetonitrile (300 mL) was added oven-dried anhydrous potassium fluoride (1.5 mol) and the mixture was stirred at room temperature for three hours (monitoring by ¹H NMR spectroscopy). Longer times are required for large-scale preparations. Following the removal of potassium chloride by filtration, the filtrate was concentrated and the residue was recrystallized (MeCN-Et2O) to give TFFH (8) as non-hygroscopic, white crystals in 92% yield.

Scheme 4 Synthesis of TFFH
The above method has been modified for a one-pot preparation, [²9] as follows:
In a one-liter, three-necked flask equipped with a mechanical stirrer, an addition funnel, and a reflux condenser, oxalyl chloride was added over a period of 10 minutes to a solution of 1,1,3,3-tetramethylurea in anhydrous dichloromethane with vigorous stirring. The reaction mixture was refluxed for three hours and the solvent was removed under reduced pressure. The residue was washed twice with anhydrous diethyl ether and dissolved in anhydrous acetonitrile. Then, a predried mixture of potassium fluoride (3 equiv) and potassium hexafluorophosphate (1 equiv) was added. The resulting mixture was heated at 60 ˚C for three hours, then the reaction mixture was cooled to room temperature, filtered, and washed with acetonitrile. The combined filtrate was concentrated, the resulting oily residue was taken up in hot dichloromethane, and the cloudy solution was filtered while hot and concentrated under reduced pressure to approximately half the volume. Anhydrous diethyl ether was added with vigorous stirring to promote precipitation of the salt as a white solid, in a yield of 91%.
4 Solution and Solid-Phase Peptide Coupling Using TFFH
Not only does the acid fluoride methodology coexist well with acid-sensitive groups [tert-butoxycarbonyl (Boc) and tert-butyl side-chain-protecting groups, see Section 2], it is the unique acyl fluoride functionality itself that is likely to assure the widespread applicability of this general class of reagents. [¹²a] [²0] [³0] Due to the nature of the C-F bond, acyl fluorides are of greater stability than the corresponding chlorides toward neutral oxygen nucleophiles such as water or methanol, yet appear to be of equal or nearly equal reactivity toward anionic nucleophiles and amines. [¹²a] [¹³c] [²0]
Use of the fluoroformamidinium salts TFFH (8) and BTFFH (9) was shown to be as effective as the isolated acid fluorides in either solution or solid-phase peptide assembly. Arginine, however, represents a special case. Reaction between Fmoc-Arg(Pbf)-OH (Pbf = 2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-ylsulfonyl) and TFFH or BTFFH in the presence of N,N-diisopropylethylamine (1:1:2) in N,N-dimethylformamide was monitored by infrared analysis. The acid fluoride (IR: 1845 cm-¹) was generated within 2 minutes and, although it slowly cyclized to the corresponding lactam (IR: 1794 cm-¹), a significant amount of the acid fluoride remained unreacted even after 60 minutes [²0] [²¹a]
TFFH has recently been used as an in situ reagent for solid-phase peptide synthesis. In many ways TFFH is an ideal coupling reagent for solid-phase syntheses, being readily available, inexpensive, and capable of providing crude peptides of high quality. [²¹] Examples are applications to leucine enkephalin (21), [²0] the prothrombin amide 22, [²0] [²¹] ACP (65-74) (23), [³¹] bradykinin amide (24), [²¹b] human preproenkephalin (100-111) (25), [³²] insulin B-chain (19-25)(26), [²¹a] substance P (27), [³³] the peptaibols alamethicin amide (28) [³4] and magainin I amide (29), [²¹] and the leucine enkephalin analogue 30 containing adjacent Aib units in place of the Gly units (Table [¹] ). [²¹] [²²] The final system is often used as a simple model in order to compare various coupling reagents. [²²]
Entry | Compound | Amino acid sequence |
1 | 21 | H-Tyr-Gly-Gly-Phe-Leu-OH |
2 | 22 | H-Ala-Asn-Lys-Gly-Phe-Leu-Glu-Glu-Val-NH2 |
3 | 23 | H-Val-Gln-Ala-Ala-Ile-Asp-Tyr-Ile-Asn-Gly-NH2 |
4 | 24 | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-NH2 |
5 | 25 | H-Tyr-Gly-Gly-Phe-Met-Lys-Arg-Tyr-Gly-Gly-Phe-Met-NH2 |
6 | 26 | H-Cys-Gly-Glu-Arg-Gly-Phe-Phe-NH2 |
7 | 27 | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 |
8 | 28 | Ac-Aib-Pro-Aib-Ala-Aib-Ala-Glu-Aib-Val-Aib-Gly-Leu-Aib-Pro-Val-Aib-Aib-Glu-Gln-Phe-NH2 |
9 | 29 | H-Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Gly-Lys-Phe-Gly-Lys-Ala-Gly-Glu-Ile-Met-Lys-Ser-NH2 |
10 | 30 | H-Tyr-Aib-Aib-Phe-Leu-NH2 |
Using N,N-dimethylformamide as solvent and an instrument programmed for 7 minutes of preactivation, 7 minutes of deblocking, and 30 minutes of coupling [fivefold excess of acid, tenfold excess of base (DIPEA)] for all amino acids, except in the case of Aib-Aib for which a one-hour double coupling was used, pentapeptide 30 was obtained in 88% yield with a purity of crude product of 92% (amount of des-Aib tetrapeptide: 4%). [²¹] In contrast, under similar conditions, earlier syntheses [²³b] using HATU and HBTU gave the pentapeptide in 94% purity and 43% purity, [²0] respectively.
5 Synthesis of Small Phosphotyrosine-Containing Peptides and Peptide Mimetics Incorporating α-Methylated Amino Acids
A series of small phosphotyrosine-containing peptides with the sequence mAZ-pTyr-Xaa-Asn-NH2 (mAZ = m-aminobenzyloxycarbonyl) (Figure [7] ) were synthesized as highly potent inhibitors of the Grb2-SH2 domain; [³5] these systems are important for signal transduction. [³5] [³6] Couplings involving α-methylated amino acids were carried out using TFFH. Other amino acids were introduced via standard coupling techniques. The building block Fmoc-l-(α-Me)Tyr(PO3Bn)2-OH was synthesized following the general methods for preparing protected phosphotyrosine. [³7-³9]

Figure 7 Small phosphotyrosine-containing peptides
6 Synthesis of Lysine Analogues
Lysine analogues have been introduced into pseudopeptide sequences by use of the acyl fluoride methodology. [40] [4¹] In order to synthesize such compounds, it is necessary to use a single synthon which would afford a wide range of pseudopeptides. Such a strategy relies upon the unique properties of the triflate derivatives 31 of 6-(benzyloxycarbonylamino)hexanoic acid derivatives. Triflates 31 can easily be obtained through a four-step sequence starting from lysine. [40] Triflates 31 could be treated with various nucleophiles to afford the 2-substituted derivatives (Scheme [5] ). The coupling step of the secondary amines obtained by reaction of the triflate 32 with primary amines, with an aspartic acid derivative with proper protection of the α-amino and side-chain carboxylic acid groups, was investigated (Scheme [6] ). [40] From the different activation methods screened (PyBroP, PyBOP, mixed anhydride), only the acyl fluoride method using TFFH gave a consistently good yield (60-80%) whatever the amino component. [40]

Scheme 5 Synthesis of l-lysine analogues: (a) ROH/H+; (b) Z-OSu, Et3N; (c) BzlBr, Et3N, acetone; (d) Tf2O, lutidine, CH2Cl2; (e) nucleophile, Et3N; (f) TFFH (1.2 equiv), DIPEA (2 equiv) CH2Cl2.

Scheme 6 Preparation of pseudotripeptides: (a) Z-OSu, Et3N; (b) WSC (water soluble carbodiimide, 1.5 equiv), DIPEA (3 equiv), HOBt (1 equiv), ProOBut (1.2 equiv); (c) Tf2O, lutidine, -78 ˚C; (d) H2NOBn (5 equiv); (e) NH2CH2CH=CH2, Et3N (4 equiv); (f) TFFH (1.2 equiv), DIPEA (2 equiv), CH2Cl2.
7 Synthesis of Proline Conformation in Tripeptide Fragments of Bovine Pancreatic Ribonuclease A Containing the Nonnatural Proline Analogue 5,5-Dimethylproline
Based on the sequence of residues 92-94 (Tyr-Pro-Asn) and 113-115 (Asn-Pro-Tyr) in bovine pancreatic ribonuclease A, in which the X-Pro peptide groups are in the cis conformation, the tripeptides Ac-Tyr-dmP-Asn and Ac-Asn-dmP-Tyr (L-dmP = l-5,5-dimethylproline) were synthesized using the Fmoc-amino acids strategy with TFFH as coupling reagent in the presence of DIPEA as a base. This gave a higher yield (75%) than the TBTU strategy (58%). [4²]
8 Synthesis of Different Types of Dipeptide Building Units Containing N- or C-Terminal Arginine for the Assembly of Backbone Cyclic Peptides
Different types of dipeptide building units containing N- or C-terminal arginine were prepared for the synthesis of backbone cyclic analogues of the peptide hormone bradykinin (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg). [4³] In order to avoid lactam formation of the N-terminal arginine to the alkylated amino acids at position 2 during the condensation, the guanidine function has to be protected. The best results were obtained upon coupling Z-Arg(Z2)-OH with TFFH/collidine in dichloromethane. Another dipeptide building unit with an acylated reduced peptide bond containing C-terminal arginine was prepared to synthesize bradykinin analogues with backbone cyclization at the C-terminal.
9 Synthesis of Peptidyl Methylcoumarin Esters as Substrates and Active-Site Titrants for Prohormone Processing
Although peptidyl methylcoumarin amides are well established as model substrates for understanding protease specificity, the corresponding methylcoumarin esters have attracted scant attention despite their potential utility in active-site titration mechanistic characterization. Initial attempts to synthesize methylcoumarn esters via a modification of the well-established isobutyl chloroformate coupling procedure used to prepare methylcoumarin amides gave low yields and extensive racemization. [44] Several other coupling reagents gave only trace amounts of product. Transesterification of commercially available protected p-nitrophenyl esters proceeded readily, but the resulting products were contaminated with trace amounts of p-nitrophenol, which proved incompatible with subsequent manipulations. As described, [44] the best results were obtained via DCC coupling with 1.2-2.0 equivalents of 7-hydroxy-4-methylcoumarin (β-methylumbelliferone, hymecromone) using N-methylmorpholine as base and ethyl acetate-N-methyl-2-pyrrolidinone as solvent. Poor results were obtained with ethyl acetate as sole solvent because of the low solubility of the alcohol. Attempts to couple the methylcoumarin (α-amino) esters (α-amino MCEs) to tripeptides using standard segment-coupling conditions gave poor yields and unacceptable levels of racemization. After an extensive survey of coupling reagents and protocols, the optimal results were obtained by activating tripeptides with the coupling reagent TFFH at 0 ˚C. The α-amino ester was then added slowly under argon and allowed to react overnight at 4 ˚C. Some racemization of the activated residue in the tripeptide occurred with this procedure (<13%), but the epimers were separable by HPLC; however, such purification has proven unnecessary, because interference from minor epimers has not affected the characterization of serine proteases with these compounds. Additionally, in all cases examined, racemization at the MCE-containing C-terminal residue itself has been undetectable. This procedure has been successfully used to prepare a number of tetrapeptidyl methylcoumarin esters 33 (Scheme [7] ), including Z-Ala-Tyr-Lys-Lys-MCE, Z-Nle-Tyr-(Boc)Lys-Arg(Mtr)-MCE (Mtr = 4-methoxy-2,3,6-trimethylphenylsulfonyl), Z-Nle-Tyr-Lys-(d-Lys)-MCE, and Z-(d-Nle)-Tyr-Lys-Lys-MCE.

Scheme 7 Synthesis of tetrapeptidyl methylcoumarin esters
10 Synthesis of Boc-( N -All)Xaa-( N -All)Xaa-OMe
Dipeptides containing a N-allyl substituent on both nitrogens have been prepared from the N-alkylated amino acids and N-alkylated amino acid esters in the presence of TFFH as coupling reagent to afford the dipeptides in 35-75% yield. [45] The resulting dipeptides were subjected to ring-closing metathesis (RCM) using Grubbs catalyst to afford the cyclized dipeptides, [46] e.g. 34 (Scheme [8] ).

Scheme 8 Synthesis of a cyclized dipeptide
11 Synthesis of Alamethicin F30 and Analogues Using TFFH
The use of Fmoc-amino acid fluorides for the solid-phase synthesis of Aib-containing polypeptides has proved to be the method of choice for these difficult sequences. [47-49] The synthesis of alamethicin peptides N- and C-terminally modified with fullerene or lipopeptide units were carried out by in situ acid fluoride activation with TFFH- on 2-chlorotrityl chloride polystyrene resin and conjugation with fullerenes C60 and C70 was carried out in solution. [50] Further improvements were presented for automated solid-phase synthesis via generation of Fmoc-amino acid fluorides in situ using TFFH. Examples for the in situ activation with TFFH for the synthesis of difficult peptide sequences without Aib residues have been reported in a short communication. [5¹]
11.1 C-Terminal Alamethicin F30-Fullerene C 60 and C 70 Conjugates

Scheme 9 C-Terminal active ester conjugation of fullerene C60 or C70 in solution to [Phe20]alamethicin F30-2-aminoethyl amide synthesized on 2-chlorotrityl resin using in situ TFFH activation; (a) cleavage (hexafluoro-2-propanol-dichloromethane, 1 h); (b) coupling of the fullerene succinimide ester (CH2Cl2, 4 h), precipitation, and flash chromatography on silica gel; (c) deprotection [TFA-CH2Cl2 (1:1) containing 5% H2O and 2% i-Pr3SiH].
The synthesis of the two conjugates is outlined in Scheme [9] . [5²] The fully protected alamethicin F30-2-aminoethyl amide was synthesized on a PE Applied Biosystems Synthesizer 433A. [5²] The first residue Fmoc-l-phenylalanine (replacing phenylalaninol) was coupled to the resin loaded with ethane-1,2-diamine. All couplings were carried out with Fmoc-amino acid (10 equiv), TFFH (10 equiv), and N,N-diisopropylethylamine (20 equiv) in pure N,N-dimethylformamide for 60 minutes. Cleavage from the resin was performed with hexafluoro-2-propanol-dichloromethane (2:3) for one hour and, after partial concentration, the polypeptide was precipitated with n-hexane-diethyl ether (1:1). After lyophilization from tert-butyl alcohol-water (4:1) and purification by RP-HPLC, the side-chain-protected alamethicin F30-2-aminoethyl amide was acylated with 1,2-dihydro-1,2-methanofullerene(60)-61-carboxylic acid succinimide ester or 1,2-dihydro-1,2-methanofullerene(70)-71-carboxylic acid succinimide ester in dichloromethane within four hours. After precipitation with n-hexane and flash chromatography on silica gel using chloroform-methanol (9:1), the protected conjugate (35% yield) was treated with trifluoroacetic acid-dichloromethane (1:1) containing 5% water and 2% triisopropylsilane. Coordination ion-spray mass spectra (CIS-MS) showed the expected molecular ions of C-terminal [Phe20]alamethicin F30-2-aminoethyl amide-fullerene conjugates as ion adducts. [5²]

Scheme 10 N-Terminal conjugation of fullerene(60)-carboxylic acid to [Ac21]alamethicin F30 synthesized on 2-chlorotrityl resin using TFFH activation; (a) cleavage and deprotection [TFA-CH2Cl2 (1:1) containing 5% H2O and 2% i-Pr3SiH]; (b) after purification (RP-HPLC), conjugation in solution with fullerene(60)-carboxylic acid (preactivation with HATU, DIPEA, bromobenzene-DMF, 15 h).

Scheme 11 Synthesis of isothiocyanates, imidazolidine-2-thiones, and hydrazides using TFFH
11.2 N-Terminal Alamethicin F30-Fullerene C 60 Conjugate
2-Chlorotrityl chloride resin was loaded with Fmoc-l-phenylalaninol and the alamethicin sequence was built up, as outlined in Scheme [¹0] ; [5³] however, instead of attaching acetyl-α-aminoisobutyric acid as the last residue, Fmoc-Aib-OH followed by Fmoc-6-aminohexanoic acid was introduced. The 21-peptide was deprotected and cleaved from the resin with trifluoroacetic acid-dichloromethane (1:1) containing 5% water and 2% triisopropylsilane. Precipitation with n-hexane-diethyl ether, lyophilization from tert-butyl alcohol-water (4:1), and purification by HPLC on a C18 reversed-phase column yielded the free 21-peptide. N-Terminal acylation was performed with fullerene(60)-carboxylic acid (1 equiv), [5²] which was dissolved in bromobenzene-N,N-dimethylformamide (2:1) and activated with HATU (1 equiv) and N,N-diisopropylethylamine (10 equiv) for 30 minutes, and then added to the solid 21-peptide. After 15 hours, the crude conjugate was purified by flash chromatography on silica gel using chloroform-methanol (7:3) with 1% triethylamine as eluent. The product was characterized by CIS-MS. [5²] [5³]
12 Miscellaneous Examples
12.1 Synthesis of Isothiocyanates and Hydrazides
A mild and quick method has been reported for the synthesis of isothiocyanates from the corresponding amines using TFFH. [54] [55] Thus, the reaction between a primary amine, carbon disulfide, and TFFH proceeds rapidly giving the corresponding isothiocyanates 35 and 36 in good yield (Scheme [¹¹] ). With substituted ethane-1,2-diamines the corresponding substituted imidazolidine-2-thiones 37 are formed, presumably via the isothiocyanates as intermediates. TFFH activation of carboxylic acids followed by reaction with hydrazine allows synthesis of the hydrazides 38-40 (Scheme [¹¹] ) without contamination by the corresponding N,N′-diacylhydrazides (see Scheme [¹²] ). [55] This is advantageous in the case of compound 38 where the reported synthesis by hydrazinolysis of the ethyl ester gives the hydroquinone as the primary product due to the reducing properties of hydrazine. [56] If the N,N′-diacylhydrazide 41 is desired, the initially formed hydrazide will react further [57] (Scheme [¹²] ).

Scheme 12 Synthesis of N,N′-diacylhydrazides and acyl azides using TFFH
12.2 Conversion of Carboxylic Acids into Anilides and Azides [57]
Several anilides were prepared by activation of an equimolar solution of a carboxylic acid with TFFH in acetonitrile in the presence of triethylamine. Infrared examination of the reaction mixtures indicates that different active intermediates may be present (Scheme [¹³] ). Activation of Z-amino acids [N-(benzyloxycarbonyl)amino acids, urethane-type group] by means of TFFH gives initially acid fluoride 43 (IR: 1842 cm-¹) as the only detectable species. With a N-benzoylamino acid, a mixture of the acid fluoride (IR: 1840 cm-¹) and the corresponding oxazolone 44 (IR: 1830 and 1685 cm-¹) is formed and, on standing, the oxazolone is converted exclusively into the acid fluoride by attack of fluoride ion. [²0] [²¹] [57] For phenylacetic acid or cinnamic acid, mixtures of the acid fluoride and anhydride 45 (IR: 1824 and 1780 cm-¹) are formed in the ratio 1:1.

Scheme 13 Activation of carboxylic acids by means of TFFH
Activation of carboxylic acids with TFFH in the presence of sodium azide and triethylamine was carried out similarly (see Scheme [¹²] ). Infrared examination of the reaction mixture after five minutes showed the presence of the acyl azide 42 (IR: 2100 cm-¹) and traces of the acyl fluoride. Eventually, the acyl fluoride disappeared completely (ca. 1 h). [57]
12.3 Acylation of Alcohols, Thiols, and Dithiocarbamates [58]

Figure 8
Couplings of carboxylic acids with various nucleophiles to produce esters, amides, thioesters, etc. belong to the most widely employed transformations in organic chemistry. [59] Many procedures call for excess alcohol and strong Lewis or Brønsted acid catalysis. [60] Modern coupling reagents utilize only an equimolar amount of acid and nucleophile. Conditions are mild and compatible with a wide variety of functional groups, including the most common protecting groups. [6¹]
N,N′-Dicyclohexylcarbodiimide (DCC, 18) is one of the most widely used condensation agents in organic chemistry because it is inexpensive and can be used under mild reaction conditions. [6²] DCC was introduced by Sheehan and Hess [6³] in 1955 and was crucial for completion of the first total synthesis of penicillin V; [64] however, it has the disadvantage of being of low reactivity as well as leading to an insoluble N-acylurea byproduct. [65] Halo uronium salts such as the highly reactive 2-chloro-1,3-dimethylimidazolium hexafluorophosphate ( CIP, 46) (Figure [8] ) and N,N,N′,N′-tetramethylchloroformamidinium hexafluorophosphate (TCFH, 20) (see Scheme [4] ) have only recently received attention for their use as dehydrating agents in the formation of carboxylic acid derivatives other than amides. [66]
Boas and co-workers [67] reported the use of TFFH in the synthesis of esters 47 and thioesters 48 via in situ acid fluoride formation (Scheme [¹4] ). It was also shown that TFFH is effective in giving thioacids 49 upon reaction with a carboxylic acid and sodium sulfide. The thioacids are easily converted into thioesters by reaction with alkyl bromides (Scheme [¹4] ).

Scheme 14 Synthesis of esters, thioesters, and thioacids using TFFH
Acylation proceeds smoothly upon addition of triethylamine to a concentrated solution of a carboxylic acid and one equivalent of TFFH in a variety of solvents, such as dichloromethane, chloroform, or N,N-dimethylformamide. All reactions proceed in high yield with little or no side reactions, and are catalyzed by the addition of DMAP (typically 5-10%). Inert atmosphere is only necessary if the reactants/products are air-sensitive. Figure [9] depicts a number of esters 50-58 that were prepared from the acid and the corresponding alcohol via the acid fluoride using TFFH as the fluorinating agent. A wide range of functionalities is compatible with the mild esterification conditions.

Figure 9 Esters synthesized using TFFH as fluorinating agent
Both linear and highly hindered alcohols can be used (Figure [9] ), and even the extremely acid-sensitive 4,4′-dimethoxytrityl group can be present, which makes the esterification procedure useful in the preparation of protected nucleotides for the automated synthesis of nucleosides. Bromo ester 54 has been prepared conveniently on a 30-gram scale, demonstrating that scaling up of TFFH reactions is feasible. Sensitive esters, such as 55, and acrylic acid esters, e.g. 56, were also prepared using TFFH. The acrylic acid does not complicate the esterification procedure which was superior to the coupling reaction between acryloyl chloride and the corresponding alcohol.
The procedure works well with the difficult ferrocenecarboxylic acid, giving esters 57 and 58. These ferrocene derivatives are of interest in connection with the development of aromatic building blocks for application in liquid crystal displays and other disciplines within the field of materials science. It has been reported that 4,4′-dihydroxybiphenyl can be monoesterified in moderate yield with TFFH. [67]
Thioesters are also useful compounds in the field of materials science, and their preparation has been demonstrated in two different ways. [58] The first route proceeds via coupling between an acid fluoride, prepared from the corresponding carboxylic acid, and a thiol, as shown in Scheme [¹4] . The second route involves reaction between a carboxylic acid, TFFH, and sodium sulfide to give the sodium salt of the corresponding thioacid, as outlined in Scheme [¹4] . Reaction with an alkyl halide then gives the desired thioester (Figure [¹0] ). Chemoselective acylation of dithiocarbamates from in situ generated acid fluorides and thiazolidine-2-thione has been accomplished using TFFH (Scheme [¹5] , Figure [¹0] ). These derivatives are useful for the preparation of aldehydes from the corresponding carboxylic acids by reduction with diisobutylaluminum hydride, but preparation of the acylated thiazolidine-2-thione usually proceeds via a thallium(I) salt making the synthetic procedure somewhat unattractive. [67]

Scheme 15 Chemoselective N-acylation of thiazolidine-2-thione using TFFH

Figure 10 Examples of thioesters and N-acylthiazolidine-2-thiones synthesized using TFFH as fluorinating agent

Scheme 16 Synthesis of alcohols and hydroxamic acids using TFFH/PTF
12.4 Conversion of Carboxylic Acids into Alcohols and Hydroxamic Acids Using TFFH/PTF [²8]
The poor results obtained with some aryl carboxylic acids in the presence of TFFH (8) can be improved by using PTF (16) as an additive during the preactivation step. The resulting such fluorides can be reduced to the corresponding primary alcohols or converted into the hydroxamic acids 64 by reaction with sodium borohydride or hydroxylamine, respectively (Scheme [¹6] ). Addition of the fluoride additive (PTF) avoids symmetric anhydride formation and allows maximum formation of the acid fluoride. [²7] [²8]
12.5 Preparation of 2-Aminobenzimidazole, 2-Aminobenzoxazole, and 2-Aminobenzothiazole Derivatives [68]
Formamidinium salts have been mainly used as coupling reagents in peptide synthesis by activation of the carboxyl group of the amino acid; however, during the much slower activation of hindered amino acids, protected peptide segments, or carboxylic acids involved in cyclization, the formamidinium salts may undergo reaction with the amino component to give the corresponding guanylated derivatives. [69] Recently, advantage was taken of this side reaction which was used for the synthesis of 1,1,3,3-tetrasubstituted 4-aminoguanidines 65, as well as the [1,2,4]triazolo derivatives 67 and 69 [70] (Scheme [¹7] ).

Scheme 17 Synthesis of 1,1,3,3-tetrasubstituted 4-aminoguanidines and [1,2,4]triazolo derivatives using TFFH
Interestingly, compounds such as 2-benzyl-3-hydrazinoquinoxaline (66) or 1-hydrazinophthalazine hydrochloride (68) react with formamidinium salts in a different manner to normal under similar conditions. In these cases, the intermediate guanidine undergoes heterocyclization to give the corresponding [1,2,4]triazolo derivatives 67 and 69. [7¹] [7²]
Similar reactions occur in the case of o-substituted anilines, such as 2-aminophenol (70a), benzene-1,2-diamine (70b), and 2-aminothiophenol (70c), which give 2-aminobenzoxazole, 2-aminobenzimidazole, and 2-aminobenzothiazole derivatives 73a, 73b, and 73c, respectively (Scheme [¹8] ). [68] Compounds 73 could be formed by two alternative routes (A or B), depending on the nucleophilicity of substituent X. For route A, if X = S it is more nucleophilic than the aniline nitrogen atom, and X attacks the central carbon atom of the formamidinium salt to give an intermediate which then undergoes in situ heterocyclization with the loss of dimethylamine from intermediate 71 to give product 73c. For route B, the aniline nitrogen atom first attacks the central carbon atom of the formamidinium salt to give intermediate 72 which then undergoes in situ intramolecular cyclization to afford the azole derivatives 73a or 73b (Scheme [¹8] ).

Scheme 18 Synthesis of azole derivatives using TFFH
12.6 Formation of Interchain Carboxylic Anhydrides on Self-Assembled Monolayers [7²]
Recently, self-assembled monolayers (SAMs) were introduced as an ideal platform for studying the rules that govern ‘reactions in two dimensions’. SAMs are highly ordered molecular assemblies which are formed spontaneously by chemisorption of functionalized surfactants onto solid surfaces. [7³] The well-defined, highly controllable structures of SAMs provide great advantages for the design of two-dimensional systems for investigating interfacial phenomena or reaction behavior. [74] [75] Reactions on SAMs are also crucial for the design of surfaces for further applications, such as the construction of biochips via the tethering of biologically active molecules. [75] Therefore, it is of practical importance for efficient surface-tailoring to understand the characteristic behavior of SAM-based reactions. Such phenomena often have no analogies in solution-based reactions. [76] For example, because of their being densely packed and highly ordered, SAM-based reactions often show pronounced steric effects. [77-80] SAMs of 16-mercaptohexadecanoic acid were formed on gold and treated with cyanuric fluoride and pyridine to generate the acid fluoride. [8¹] Two different products, acid fluoride and interchain carboxylic anhydride (ICA), [80] were controllably obtained under different reaction conditions with the same reagents. With TFFH, the reaction pathway is very similar to that with cyanuric fluoride, and IR peaks for the carboxylic acid group (1742 and 1719 cm-¹) disappeared and two new peaks appeared at 1821 and 1754 cm-¹. No peak appeared at 1840 cm-¹, as would be expected for the acid fluoride. The two new peaks are characteristic for the anhydride (Scheme [¹9] ).
When the amount of pyridine was fixed and the concentration of TFFH was increased along with an increase in the reaction time, predominantly ICA formed at the surface with acid fluoride as a minor product. When the amount of TFFH was fixed and the amount of pyridine was varied, ICA was still formed at the surface as the major product and no change in the product distribution was observed. Addition of tetrabutylammonium fluoride dramatically changed the surface product to that of the acid fluoride. The surface was fully covered with acid fluoride via decomposition of the ICA. [8²] [8³]
12.7 Synthesis of the A 1 B(A)C Fragment of Everninomicin 13,384-1 [84] [85]
Everninomicin 13,384-1 (Ziracin™, 74) (Figure [¹¹] ), a member of the orthosomicin class of antibiotics. [86] [87] The total synthesis of everninomicin 13,384-1 (74) using a number of novel synthetic strategies and methods has been reported. [84] The A1B(A)C fragment 75 (Figure [¹²] ), which is the phenylseleno fluoride fragment, consists of four building blocks. A more efficient synthesis than the one previously reported [88] for the aromatic fluoride fragment 76 was developed and is summarized in Scheme [²0] . TFFH was used and afforded the acyl fluoride derivative in 97% yield.

Figure 11 Everninomicin 13,384-1 (74)

Figure 12 Structure of the A1B(A)C fragment 75
The same method was employed for preparation of the acyl fluoride derivative used in the synthesis of the FGHA2 fragment 77 (Figure [¹³] ) of everninomicin 13,348-1, in an overall yield of 80%. [89]

Figure 13 Structure of the FGHA2 fragment 77

Scheme 19 Proposed mechanism for the formation of interchain carboxylic anhydride

Scheme 20 Synthesis of acyl fluoride 76 using TFFH
12.8 Synthesis of Chiral Polyionic Dendrimers with Complementary Charges [90]
Dendrimers, regularly branched polymers of well-defined size, have been very actively studied in recent years. [90] As synthetic techniques are now well developed, the interest has shifted towards taking advantage of the properties of these unique macromolecules in various applications such as catalysis and molecular recognition. [9¹] [9²] The dendrimer is assembled in a convergent, or outside-in, fashion (Scheme [²¹] ). Deprotection of the appropriate groups of monomer A yielded 78 and 79. These derivatives were not isolated, but were subjected to coupling by means of TFFH. To ensure complete coupling, a double acylation of 78 with TFFH-activated 79 (2 + 2 equiv) was carried out. This provided the dendritic wedge 80 in 62% yield. Hydrogenolytic removal of the focal-point protecting group yielded carboxylic acid 81, while deprotection of the core phenyltrisalanine derivative 82 gave triamine 83. Coupling of 81 and 83, without prior isolation of these fragments, finally furnished G2A dendrimer 84 in 69% yield.
G2B dendrimer 85 was assembled analogously (Scheme [²²] ). Deprotection of monomer B yielded derivatives 86 and 87 which could be coupled in a 1:2 ratio to give dendritic wedge 88 in 62% yield. Deprotection of the focal-point amine gave wedge 89, which was coupled in a 4:1 ratio with phenyltrisalanine derivative 91, obtained from 82 by protecting group manipulations via 90. The coupling furnished G2B dendrimer 85 in 39% yield. Also, the corresponding dendrimers of the first generation, G1A 92 (Figure [¹4] ), obtained from 79 and 83 in a 4:1 ratio, and G1B 93 and dendrimer 94 (Figure [¹5] ), were synthesized using TFFH and the same methodology as for the G2 dendrimers.

Scheme 21 Synthesis of chiral polyionic G2A dendrimer 84

Scheme 22 Synthesis of chiral polyionic G2B dendrimer 85

Figure 14

Figure 15
13 Conclusion
Tetramethylfluoroformamidinium hexafluorophosphate (TFFH), a nonhygroscopic salt stable to handling under ordinary conditions, is obtained via reaction of tetramethylchloroformamidinium hexafluorophosphate (TCFH) with excess anhydrous potassium fluoride. TFFH appears to be an ideal coupling reagent for peptide synthesis in solid- and solution-phase synthesis as well as organic synthesis. TFFH is readily available, inexpensive, and capable of providing crude peptides as well as organic compounds such as carboxylic acid derivatives and heterocycles of high quality.
Acknowledgment
Professor L. A. Carpino, Professor of Organic Chemistry, University of Massachusetts, Amherst, U.S.A., is thanked for his support and advice during preparation of this Account. Professor Fernando Albericio, Professor of Organic Chemistry and the Director of Barcelona Science Park, Spain, is thanked for his support and advice.
- 1a
Elmore DT. In Amino Acids, Peptides, and Proteins Vol. 33:Barrett GC.Davies JS. The Royal Society of Chemistry; Cambridge: 2002. p.83 - 1b
Li P.Xu JC. J. Pept. Res. 2001, 58: 129 - 1c
Peptide
Chemistry: Design and Synthesis of Peptides, Conformational Analysis and
Biological Functions
Hruby VJ.Schwyzer R. Pergamon; Oxford: 1998. - 1d
Humphrey JM.Chamberlin AR. Chem. Rev. 1997, 97: 2243 - 1e
Carpino LA.Beyermann M.Wenschuh H.Bienert M. Acc. Chem. Res. 1996, 29: 268 - 1f
Bailey PD. An Introduction to Peptide Chemistry Wiley; Chichester: 1990. - 1g
Bodanszky M. Principles of Peptide Synthesis Springer; Berlin: 1984. - 1h
Klausner YS.Bodanszky M. Synthesis 1972, 453 - 2 For a review of the work on the
use of protected amino acid chlorides, see:
Schröder E.Lübke K. The Peptides, Methods of Peptide Synthesis Vol. 1: Academic Press; New York: 1965. p.77 - 3
Fischer E.Otto E. Ber. Dtsch. Chem. Ges. 1903, 36: 2106 - 4
Weisz I.Roboz J.Bekesi G. Tetrahedron Lett. 1996, 37: 563 - 5
Rozov LA.Rafalko PW.Evans SM.Brockunier L.Ramig K. J. Org. Chem. 1995, 60: 1319 - 6a
Zhang L.-H.Chung JC.Costello TD.Valvis I.Ma P.Kauffman S.Ward R. J. Org. Chem. 1997, 62: 2466 - 6b
Lenman MM.Lewis A.Gani D. J. Chem. Soc., Perkin Trans. 1 1997, 2297 - 6c
Carpino LA.Cohen BJ.Stephens KE.Sadat-Aalaee Y.Tien J.-H.Langridge DC. J. Org. Chem. 1986, 51: 3732 - 7a
Senokuchi K.Nakai H.Nagao Y.Sakai Y.Katsube N.Kawamura M. Bioorg. Med. Chem. 1998, 6: 441 - 7b
Wissner A.Grudzinskas CV. J. Org. Chem. 1978, 43: 3972 - 8
Venkataraman K.Wagle DR. Tetrahedron Lett. 1979, 3037 - 9
Kaminski ZJ. Synthesis 1987, 917 - 10a
Thern B.Rudolph J.Jung G. Tetrahedron Lett. 2002, 43: 5013 - 10b
Falb E.Yechezkel T.Salitra Y.Gilon C. J. Pept. Res. 1999, 53: 507 - 10c
Zouikri M.Vicherat A.Aubry A.Marraud M.Boussard G. J. Pept. Res. 1998, 52: 19 - 11
Bodanszky M. Principles of Peptides Synthesis 2nd ed.: Springer-Verlag; Berlin: 1993. p.11 - 12a
Carpino LA.Sadat-Aalaee D.Chao HG.DeSelms RH. J. Am. Chem. Soc. 1990, 112: 9651 - 12b
Bertho J.-N.Loffet A.Pinel C.Reuther F.Sennyey G. Tetrahedron Lett. 1992, 33: 1303 - 12c
Carpino LA.Mansour EME.Sadat-Aalaee D. J. Org. Chem. 1991, 56: 2611 - 13a
Kim Y.-A.Han S.-Y. Bull. Korean Chem. Soc. 2000, 21: 943 - 13b
Šavrda J.Chertanova L.Wakselman M. Tetrahedron 1994, 50: 5309 - 13c
Carpino LA.Mansour EME.El-Faham A. J. Org. Chem. 1993, 58: 4162(14) - 14a
Lal GS.Pez GP.Pesaresi RJ.Prozonic FM.Cheng H. J. Org. Chem. 1999, 64: 7048 - 14b
Badu SVV.Gopi HN.Ananda K. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 2000, 39: 384 - 15a
Li P.Xu J.-C. Tetrahedron 2000, 56: 8119 - 15b
Li P.Xu JC. Chem. Lett. 2000, 204 - 16
Mukaiyama T.Tanaka T. Chem. Lett. 1976, 303 - 17
Wittmann R. Chem. Ber. 1963, 96: 771 - 18
Olah GA.Nojima M.Kerekes I. Synthesis 1973, 487 ; and references cited therein - 19a
Yarovenko NN.Radsha MA. J. Gen. Chem. USSR (Engl. Transl.) 1959, 29: 2125 - 19b
Olah GA.Nojima M.Kerekes I. J. Am. Chem. Soc. 1974, 96: 925 - 20
Carpino LA.El-Faham A. J. Am. Chem. Soc. 1995, 117: 4101 - 21a
El-Faham A. Chem. Lett. 1998, 671 - 21b
El-Faham A. Org. Prep. Proced. Int. 1998, 30: 47 - 21c
Akaji K.Kuriyama N.Kiso Y. Tetrahedron Lett. 1994, 35: 3315 - 22
El-Faham A.Khattab SN.Abdul-Ghani M.Albericio F. Eur. J. Org. Chem. 2006, 1563 - 23a
Carpino LA.Imazumi H.El-Faham A.Ferrer FJ.Zhang C.Lee Y.Foxman BM.Henklein P.Hanay C.Mugge C.Wenschuh H.Klose J.Beyermann M.Bienert M. Angew. Chem. Int. Ed. 2002, 41: 441 - 23b
Carpino LA.El-Faham A.Minor CA.Albericio F. J. Chem. Soc., Chem. Commun. 1994, 201 - 24
Carpino LA. J. Am. Chem. Soc. 1993, 115: 4397 - 25a
Dourtoglu V.Gross B.Lambropoulou V.Zioudrou C. Synthesis 1984, 572 - 25b
Knorr R.Terciak A.Bannworth W.Gillessen D. Tetrahedron Lett. 1989, 30: 1927 - 26
Fiammengo R.Licini G.Nicotra A.Modena G.Pasquato L.Scrimin P.Broxterman QB.Kaptein B.
J. Org. Chem. 2001, 66: 5905 - 27
Carpino LA.Ionescu D.El-Faham A.Beyermann M.Henklein P.Hanay C.Wenschuh H.Bienert M. Org. Lett. 2003, 5: 975 - 28
El-Faham A.Kattab SN.Abdul-Ghani M. ARKIVOC 2006, (xiii): 57 - 29
Vojkovsky T.Drake B. Org. Prep. Proced. Int. 1997, 29: 497 - 30
Bertho J.-N.Loffet A.Pinel C.Reuther F.Sennyey G. Tetrahedron Lett. 1991, 32: 1303 - 31
Hudson D. J. Org. Chem. 1988, 53: 617 - 32
Izdebski J.Bondaruk J.Gumulka SW.Krzascik P.
Int. J. Pept. Protein Res. 1989, 33: 77 - 33
Carey RI.Bordas LW.Slaughter RA.Meadows BC.Wadsworth JL.Huang H.Smith JJ.Furusjo E. J. Pept. Res. 1997, 49: 570 - 34 For the first solid-phase synthesis
of these hindered sequences via isolated amino acid fluorides, see:
Wenschuh H.Beyermann M.Krause E.Brudel M.Winter R.Schumann M.Carpino LA.Bienert M. J. Org. Chem. 1994, 59: 3275 - 35
Liu WQ.Vidal M.Gresh N.Roques PB.Garbay C. J. Med. Chem. 1999, 42: 3737 - 36
Chardin P.Cussac D.Maignan S.Ducruix A. FEBS Lett. 1995, 369: 47 - 37
Perich JW.Ruzzene M.Pinna LA.Reynolds EC.
Int. J. Pept. Protein Res. 1994, 43: 39 - 38
Williams RM.Im MN. J. Am. Chem. Soc. 1991, 113: 9276 - 39
Furet P.Gay B.García-Echeverría C.Rahuel J.Fretz H.Schoepfer J.Caravatti G. J. Med. Chem. 1997, 40: 3551 - 40
Weber I.Potier P.Thierry J. Tetrahedron Lett. 1999, 40: 7083 - 41
Lenfant M.Wdzieczak-Bakala J.Guittet E.Prome J.-C.Sotty D.Frindel E. Proc. Natl. Acad. Sci. U.S.A. 1989, 86: 779 - 42
An SSA.Lester CC.Peng J.-L.Li Y.-J.Rothwarf DM.Welker E.Thannhauser TW.Zhang LS.Tam JP.Scheraga HA. J. Am. Chem. Soc. 1999, 121: 11558 - 43
Schumann C.Seyfarth L.Geriner G.Reissmann S.
J. Pept. Res. 2000, 55: 428 - 44
Müller B.Besser D.Kleinwächer P.Arad O.Reissmann S. J. Pept. Res. 1999, 54: 383 - 45
Rockwell NC.Krysan DJ.Fuller RS. Anal. Biochem. 2000, 280: 201 - 46
Reichwein JF.Liskamp RMJ. Eur. J. Org. Chem. 2000, 2335 - 47
Triolo SA.Ionescu D.Wenschuh H.Sole NA.El-Faham A.Carpino LA.Kates SA. In Peptides 1996, Proceedings of the 24th European Peptide SymposiumRamage R.Epton R. Mayflower Scientific; Kingswinford U.K.: 1998. p.839-840 - 48
Wenschuh H.Beyermann M.Haber H.Seydel JK.Krause E.Bienert M. J. Org. Chem. 1995, 60: 405 - 49
Schmitt H.Jung G. Liebigs Ann. Chem. 1985, 321 - 50
Jung G.Redemann T.Kroll K.Meder S.Hirsch A.Boheim G. J. Pept. Sci. 2003, 9: 784 - 51
Redemann T.Jung G. In Situ Fluoride Activation Allows the Preparation of Peptides Not Accessible by Routine Synthesis Protocols, In Peptides 1996, Proceedings of the 24th European Peptide SymposiumRamage R.Epton R. Mayflower Scientific; Kingswinford U.K.: 1998. p.749 - 52
Skiebe A.Hirsch A. J. Chem. Soc., Chem. Commun. 1994, 335 - 53
Bayer E.Gfrörer P.Rentel C. Angew. Chem. Int. Ed. 1999, 38: 992 - 54
Boas U.Pedersen B.Christensen JB. Synth. Commun. 1998, 28: 1223 - 55
Boas U.Gertz H.Christensen JB.Heegaard PMH. Tetrahedron Lett. 2004, 45: 269 - 56
Klingsberg E. J. Am. Chem. Soc. 1958, 80: 5786 - 57
El-Faham A.Abdul-Ghani M. Org. Prep. Proced. Int. 2003, 35: 369 - 58
Pittelkow M.Kamounah FS.Boas U.Pedersen B.Christensen JB. Synthesis 2004, 2485 - 59a
Albericio F.Chinchilla R.Dodsworth DJ.Nájera C. Org. Prep. Proced. Int. 2001, 33: 203 - 59b
Han SY.Kim YA. Tetrahedron 2004, 60: 2447 - 59c
March J. Advanced Organic Chemistry 4th ed.: Wiley-Interscience; New York: 1992. p.904 - 60
Comprehensive
Organic Functional Group Transformations
Vol. 5:
Katritzky AR.Meth-Cohn O.Rees CW. Elsevier; Oxford: 1995. p.121 - 61
Greene T.Wuts PGM. Protective Groups in Organic Synthesis 3rd ed.: Wiley; New York: 1999. - 62a
Fiesser LF.Fiesser M. Reagents for Organic Synthesis Vol. 1: Wiley & Sons; New York: 1967. p.231 - 62b
Encyclopedia
of Reagents for Organic Synthesis
Vol. 3:
Paquette LA. Wiley & Sons; West Sussex: 1995. p.1751 - 63
Sheehan LC.Hess GP. J. Am. Chem. Soc. 1955, 77: 1067 - 64a
Sheehan JC.Henery-Logan KR. J. Am. Chem. Soc. 1957, 79: 1262 - 64b
Nicolaou KC.Sorensen EJ. Classics in Total Synthesis Vol. 1:Corey EJ. VCH Publishers; New York: 1996. - 65
Holmberg K.Hansen B. Acta Chem. Scand., Ser. B 1979, 33: 410 - 66a
Isobe T.Ishikawa T. J. Org. Chem. 1999, 64: 6984 - 66b
Fujisawa T.Tajima K.Sato T. Bull. Chem. Soc. Jpn. 1983, 56: 3529 - 66c
Fujisawa T.Mori T.Fukumoto K.Sato T. Chem. Lett. 1982, 1891 - 66d
Isobe T.Ishikawa T. J. Org. Chem. 1999, 64: 6989 - 67a
Fujita E.Nagao Y.Seno K.Takao S.Miyasaka T.Kimura M.Watson WH. J. Chem. Soc., Perkin Trans. 1 1981, 914 - 67b
Nagao Y.Kawabata K.Seno K.Fujita E. J. Chem. Soc., Perkin Trans. 1 1980, 2470 - 68
El-Faham A.Chebbo M.Abdul-Ghani M.Younes G.
J. Heterocycl. Chem. 2006, 43: 1 - 69a
del Frenso M.El-Faham A.Carpino LA.Royo M.Albericio F. Org. Lett. 2000, 2: 3539 - 69b
Albericio F.Bofill JM.El-Faham A.Kates SA. J. Org. Chem. 1998, 63: 9678 - 69c
Gausepohl H.Pieles U.Frank RW. In Peptides: Chemistry and Biology, Proceedings of the 12th American Peptide SymposiumSmith JA.Rivier JE. ESCOM; Leiden / The Netherlands: 1992. p.523 - 70
Abdul-Ghani M.Khattab SN.El-Massry AM.El-Faham A.Amer A. Org. Prep. Proced. Int. 2004, 36: 121 - 71
Douglas EW.Hamilton S. J. Org. Chem. 2002, 67: 7553 - 72
Shik Y.Choi IS. Langmuir 2006, 22: 6956 - 73
Ulman A. Chem. Rev. 1996, 96: 1533 - 74a
Love JC.Estroff LA.Kriebel JK.Nuzzo RG.Whitesides GM. Chem. Rev. 2005, 105: 361 - 74b
Chi YS.Lee JK.Lee KB.Kim DJ.Choi IS. Bull. Korean Chem. Soc. 2005, 26: 361 - 75
Sullivan TP.Huck WTS. Eur. J. Org. Chem. 2003, 17 - 76
Chechik V.Crooks RM.Stirling CJM. Adv. Mater. 2000, 12: 1161 - 77a
Houseman BT.Mrksich M. Angew. Chem. Int. Ed. 1999, 38: 782 - 77b
Templeton AC.Hosteler MJ.Kraft CT.Murray RW. J. Am. Chem. Soc. 1998, 120: 1906 - 77c
Van Ryswyk H.Turtle ED.Watson-Clark R.Tanzer TA.Herman TK.Chong PY.Waller PJ.Taurog AL.Wagner CE. Langmuir 1996, 12: 6143 - 78a
Shimazu K.Teranishi T.Sugihara K.Uosaki K. Chem. Lett. 1998, 669 - 78b
Lee TR.Carey RI.Biebuyck HA.Whitesides GM. Langmuir 1994, 10: 741 - 78c
Bryant MA.Crooks RM. Langmuir 1993, 9: 385 - 79a
Yousaf MN.Chan EWL.Mrksich M. Angew. Chem. Int. Ed. 2000, 39: 1943 - 79b
Gawalt ES.Choi IS.Mrksich M. J. Am. Chem. Soc. 2004, 126: 15613 - 80
Chi YS.Choi IS. Langmuir 2005, 21: 11765 - 81
Olah GA.Nojima M.Kerekes I. Synthesis 1973, 487 - 82
Yan L.Marzolin C.Terfort A.Whitesides GM. Langmuir 1997, 13: 6704 - 83a
Chapman RG.Ostuni E.Yan L.Whitesides GM. Langmuir 2000, 16: 6927 - 83b
Yan L.Huck WTS.Zhao XM.Whitesides GM. Langmuir 1999, 15: 1208 - 83c
Chapman RG.Ostuni E.Liang MN.Meluleni G.Kim E.Yan L.Pier G.Warren S.Whitesides GM. Langmuir 2001, 17: 1225 - 83d
Lee KB.Kim DJ.Yoon KR.Kim Y.Choi IS. Korean J. Chem. Eng. 2003, 20: 956 - 83e
Chi YS.Choi IS. Adv. Funct. Mater. 2006, 16: 1031 - 84a
Nicolaou KC.Mitchell HJ.Suzuki H.Rodríguez RM.Baudoin O.Fylaktakidou KC. Angew. Chem. Int. Ed. 1999, 38: 3334 - 84b
Nicolaou KC.Mitchell HJ.Fylaktakidou KC.Rodríguez RM.Suzuki H. Chem. Eur. J. 2000, 6: 3116 - 85a
Ganguly AK.Pramanik B.Chan TC.Sarre O.Liu YT.Morton J.Girijavallabhan VM. Heterocycles 1989, 28: 83 - 85b
Ganguly AK. In Topics in Antibiotic Chemistry Vol. 2, Part B:Sammes PG. Wiley; New York: 1979. p.61-96 - 85c
Ganguly AK,Girijavallabhan VM,Sarre O, and . inventors; WO 87/02366. - 85d
Mahesh P,Gullo VP,Roberta H,Loebenberg D,Morton JB,Miller GH,Kwon HY, and . inventors; EP 0538011A1. - 85e
Ganguly AK.McCormick JL.Jinping LA.Saksena K.Das PR.Pradip R.Chan TM. Bioorg. Med. Chem. Lett. 1999, 9: 1209 - 86
Wright DE. Tetrahedron 1979, 35: 1207 - 87a
Ganguly AK.McCormick JL.Chan TM.Saksena AK.Das PR. Tetrahedron Lett. 1997, 38: 7989 - 87b
Chan TM.Osterman RM.Morton JB.Ganguly AK. Magn. Reson. Chem. 1997, 35: 529 - 88
Nicolaou KC.Rodríguez RM.Mitchell HJ.van Delft FL. Angew. Chem. Int. Ed. 1998, 37: 1874 ; Angew. Chem. 1998, 110, 1975 - 89
Ritzén A.Frejd T. Eur. J. Org. Chem. 2000, 3771 - 90
Nicolaou KC.Rodríguez RM.Fylaktakidou KC.Suzuki H.Mitchell HJ. Angew. Chem. Int. Ed. 1999, 38: 3340 - 91a
Newkome GR.Moorefield CN.Dendric VF. Molecules, Concepts, Synthesis, Perspectives VCH Publishers; Weinheim: 1996. - 91b
Engel R. In Advances in Dendritic Macromolecules Vol. 2:Newkome GR. JAI Press; Stamford: 1995. p.73 - 92
Fischer M.Vogtle F. Angew. Chem. Int. Ed. 1999, 38: 884
References
- 1a
Elmore DT. In Amino Acids, Peptides, and Proteins Vol. 33:Barrett GC.Davies JS. The Royal Society of Chemistry; Cambridge: 2002. p.83 - 1b
Li P.Xu JC. J. Pept. Res. 2001, 58: 129 - 1c
Peptide
Chemistry: Design and Synthesis of Peptides, Conformational Analysis and
Biological Functions
Hruby VJ.Schwyzer R. Pergamon; Oxford: 1998. - 1d
Humphrey JM.Chamberlin AR. Chem. Rev. 1997, 97: 2243 - 1e
Carpino LA.Beyermann M.Wenschuh H.Bienert M. Acc. Chem. Res. 1996, 29: 268 - 1f
Bailey PD. An Introduction to Peptide Chemistry Wiley; Chichester: 1990. - 1g
Bodanszky M. Principles of Peptide Synthesis Springer; Berlin: 1984. - 1h
Klausner YS.Bodanszky M. Synthesis 1972, 453 - 2 For a review of the work on the
use of protected amino acid chlorides, see:
Schröder E.Lübke K. The Peptides, Methods of Peptide Synthesis Vol. 1: Academic Press; New York: 1965. p.77 - 3
Fischer E.Otto E. Ber. Dtsch. Chem. Ges. 1903, 36: 2106 - 4
Weisz I.Roboz J.Bekesi G. Tetrahedron Lett. 1996, 37: 563 - 5
Rozov LA.Rafalko PW.Evans SM.Brockunier L.Ramig K. J. Org. Chem. 1995, 60: 1319 - 6a
Zhang L.-H.Chung JC.Costello TD.Valvis I.Ma P.Kauffman S.Ward R. J. Org. Chem. 1997, 62: 2466 - 6b
Lenman MM.Lewis A.Gani D. J. Chem. Soc., Perkin Trans. 1 1997, 2297 - 6c
Carpino LA.Cohen BJ.Stephens KE.Sadat-Aalaee Y.Tien J.-H.Langridge DC. J. Org. Chem. 1986, 51: 3732 - 7a
Senokuchi K.Nakai H.Nagao Y.Sakai Y.Katsube N.Kawamura M. Bioorg. Med. Chem. 1998, 6: 441 - 7b
Wissner A.Grudzinskas CV. J. Org. Chem. 1978, 43: 3972 - 8
Venkataraman K.Wagle DR. Tetrahedron Lett. 1979, 3037 - 9
Kaminski ZJ. Synthesis 1987, 917 - 10a
Thern B.Rudolph J.Jung G. Tetrahedron Lett. 2002, 43: 5013 - 10b
Falb E.Yechezkel T.Salitra Y.Gilon C. J. Pept. Res. 1999, 53: 507 - 10c
Zouikri M.Vicherat A.Aubry A.Marraud M.Boussard G. J. Pept. Res. 1998, 52: 19 - 11
Bodanszky M. Principles of Peptides Synthesis 2nd ed.: Springer-Verlag; Berlin: 1993. p.11 - 12a
Carpino LA.Sadat-Aalaee D.Chao HG.DeSelms RH. J. Am. Chem. Soc. 1990, 112: 9651 - 12b
Bertho J.-N.Loffet A.Pinel C.Reuther F.Sennyey G. Tetrahedron Lett. 1992, 33: 1303 - 12c
Carpino LA.Mansour EME.Sadat-Aalaee D. J. Org. Chem. 1991, 56: 2611 - 13a
Kim Y.-A.Han S.-Y. Bull. Korean Chem. Soc. 2000, 21: 943 - 13b
Šavrda J.Chertanova L.Wakselman M. Tetrahedron 1994, 50: 5309 - 13c
Carpino LA.Mansour EME.El-Faham A. J. Org. Chem. 1993, 58: 4162(14) - 14a
Lal GS.Pez GP.Pesaresi RJ.Prozonic FM.Cheng H. J. Org. Chem. 1999, 64: 7048 - 14b
Badu SVV.Gopi HN.Ananda K. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 2000, 39: 384 - 15a
Li P.Xu J.-C. Tetrahedron 2000, 56: 8119 - 15b
Li P.Xu JC. Chem. Lett. 2000, 204 - 16
Mukaiyama T.Tanaka T. Chem. Lett. 1976, 303 - 17
Wittmann R. Chem. Ber. 1963, 96: 771 - 18
Olah GA.Nojima M.Kerekes I. Synthesis 1973, 487 ; and references cited therein - 19a
Yarovenko NN.Radsha MA. J. Gen. Chem. USSR (Engl. Transl.) 1959, 29: 2125 - 19b
Olah GA.Nojima M.Kerekes I. J. Am. Chem. Soc. 1974, 96: 925 - 20
Carpino LA.El-Faham A. J. Am. Chem. Soc. 1995, 117: 4101 - 21a
El-Faham A. Chem. Lett. 1998, 671 - 21b
El-Faham A. Org. Prep. Proced. Int. 1998, 30: 47 - 21c
Akaji K.Kuriyama N.Kiso Y. Tetrahedron Lett. 1994, 35: 3315 - 22
El-Faham A.Khattab SN.Abdul-Ghani M.Albericio F. Eur. J. Org. Chem. 2006, 1563 - 23a
Carpino LA.Imazumi H.El-Faham A.Ferrer FJ.Zhang C.Lee Y.Foxman BM.Henklein P.Hanay C.Mugge C.Wenschuh H.Klose J.Beyermann M.Bienert M. Angew. Chem. Int. Ed. 2002, 41: 441 - 23b
Carpino LA.El-Faham A.Minor CA.Albericio F. J. Chem. Soc., Chem. Commun. 1994, 201 - 24
Carpino LA. J. Am. Chem. Soc. 1993, 115: 4397 - 25a
Dourtoglu V.Gross B.Lambropoulou V.Zioudrou C. Synthesis 1984, 572 - 25b
Knorr R.Terciak A.Bannworth W.Gillessen D. Tetrahedron Lett. 1989, 30: 1927 - 26
Fiammengo R.Licini G.Nicotra A.Modena G.Pasquato L.Scrimin P.Broxterman QB.Kaptein B.
J. Org. Chem. 2001, 66: 5905 - 27
Carpino LA.Ionescu D.El-Faham A.Beyermann M.Henklein P.Hanay C.Wenschuh H.Bienert M. Org. Lett. 2003, 5: 975 - 28
El-Faham A.Kattab SN.Abdul-Ghani M. ARKIVOC 2006, (xiii): 57 - 29
Vojkovsky T.Drake B. Org. Prep. Proced. Int. 1997, 29: 497 - 30
Bertho J.-N.Loffet A.Pinel C.Reuther F.Sennyey G. Tetrahedron Lett. 1991, 32: 1303 - 31
Hudson D. J. Org. Chem. 1988, 53: 617 - 32
Izdebski J.Bondaruk J.Gumulka SW.Krzascik P.
Int. J. Pept. Protein Res. 1989, 33: 77 - 33
Carey RI.Bordas LW.Slaughter RA.Meadows BC.Wadsworth JL.Huang H.Smith JJ.Furusjo E. J. Pept. Res. 1997, 49: 570 - 34 For the first solid-phase synthesis
of these hindered sequences via isolated amino acid fluorides, see:
Wenschuh H.Beyermann M.Krause E.Brudel M.Winter R.Schumann M.Carpino LA.Bienert M. J. Org. Chem. 1994, 59: 3275 - 35
Liu WQ.Vidal M.Gresh N.Roques PB.Garbay C. J. Med. Chem. 1999, 42: 3737 - 36
Chardin P.Cussac D.Maignan S.Ducruix A. FEBS Lett. 1995, 369: 47 - 37
Perich JW.Ruzzene M.Pinna LA.Reynolds EC.
Int. J. Pept. Protein Res. 1994, 43: 39 - 38
Williams RM.Im MN. J. Am. Chem. Soc. 1991, 113: 9276 - 39
Furet P.Gay B.García-Echeverría C.Rahuel J.Fretz H.Schoepfer J.Caravatti G. J. Med. Chem. 1997, 40: 3551 - 40
Weber I.Potier P.Thierry J. Tetrahedron Lett. 1999, 40: 7083 - 41
Lenfant M.Wdzieczak-Bakala J.Guittet E.Prome J.-C.Sotty D.Frindel E. Proc. Natl. Acad. Sci. U.S.A. 1989, 86: 779 - 42
An SSA.Lester CC.Peng J.-L.Li Y.-J.Rothwarf DM.Welker E.Thannhauser TW.Zhang LS.Tam JP.Scheraga HA. J. Am. Chem. Soc. 1999, 121: 11558 - 43
Schumann C.Seyfarth L.Geriner G.Reissmann S.
J. Pept. Res. 2000, 55: 428 - 44
Müller B.Besser D.Kleinwächer P.Arad O.Reissmann S. J. Pept. Res. 1999, 54: 383 - 45
Rockwell NC.Krysan DJ.Fuller RS. Anal. Biochem. 2000, 280: 201 - 46
Reichwein JF.Liskamp RMJ. Eur. J. Org. Chem. 2000, 2335 - 47
Triolo SA.Ionescu D.Wenschuh H.Sole NA.El-Faham A.Carpino LA.Kates SA. In Peptides 1996, Proceedings of the 24th European Peptide SymposiumRamage R.Epton R. Mayflower Scientific; Kingswinford U.K.: 1998. p.839-840 - 48
Wenschuh H.Beyermann M.Haber H.Seydel JK.Krause E.Bienert M. J. Org. Chem. 1995, 60: 405 - 49
Schmitt H.Jung G. Liebigs Ann. Chem. 1985, 321 - 50
Jung G.Redemann T.Kroll K.Meder S.Hirsch A.Boheim G. J. Pept. Sci. 2003, 9: 784 - 51
Redemann T.Jung G. In Situ Fluoride Activation Allows the Preparation of Peptides Not Accessible by Routine Synthesis Protocols, In Peptides 1996, Proceedings of the 24th European Peptide SymposiumRamage R.Epton R. Mayflower Scientific; Kingswinford U.K.: 1998. p.749 - 52
Skiebe A.Hirsch A. J. Chem. Soc., Chem. Commun. 1994, 335 - 53
Bayer E.Gfrörer P.Rentel C. Angew. Chem. Int. Ed. 1999, 38: 992 - 54
Boas U.Pedersen B.Christensen JB. Synth. Commun. 1998, 28: 1223 - 55
Boas U.Gertz H.Christensen JB.Heegaard PMH. Tetrahedron Lett. 2004, 45: 269 - 56
Klingsberg E. J. Am. Chem. Soc. 1958, 80: 5786 - 57
El-Faham A.Abdul-Ghani M. Org. Prep. Proced. Int. 2003, 35: 369 - 58
Pittelkow M.Kamounah FS.Boas U.Pedersen B.Christensen JB. Synthesis 2004, 2485 - 59a
Albericio F.Chinchilla R.Dodsworth DJ.Nájera C. Org. Prep. Proced. Int. 2001, 33: 203 - 59b
Han SY.Kim YA. Tetrahedron 2004, 60: 2447 - 59c
March J. Advanced Organic Chemistry 4th ed.: Wiley-Interscience; New York: 1992. p.904 - 60
Comprehensive
Organic Functional Group Transformations
Vol. 5:
Katritzky AR.Meth-Cohn O.Rees CW. Elsevier; Oxford: 1995. p.121 - 61
Greene T.Wuts PGM. Protective Groups in Organic Synthesis 3rd ed.: Wiley; New York: 1999. - 62a
Fiesser LF.Fiesser M. Reagents for Organic Synthesis Vol. 1: Wiley & Sons; New York: 1967. p.231 - 62b
Encyclopedia
of Reagents for Organic Synthesis
Vol. 3:
Paquette LA. Wiley & Sons; West Sussex: 1995. p.1751 - 63
Sheehan LC.Hess GP. J. Am. Chem. Soc. 1955, 77: 1067 - 64a
Sheehan JC.Henery-Logan KR. J. Am. Chem. Soc. 1957, 79: 1262 - 64b
Nicolaou KC.Sorensen EJ. Classics in Total Synthesis Vol. 1:Corey EJ. VCH Publishers; New York: 1996. - 65
Holmberg K.Hansen B. Acta Chem. Scand., Ser. B 1979, 33: 410 - 66a
Isobe T.Ishikawa T. J. Org. Chem. 1999, 64: 6984 - 66b
Fujisawa T.Tajima K.Sato T. Bull. Chem. Soc. Jpn. 1983, 56: 3529 - 66c
Fujisawa T.Mori T.Fukumoto K.Sato T. Chem. Lett. 1982, 1891 - 66d
Isobe T.Ishikawa T. J. Org. Chem. 1999, 64: 6989 - 67a
Fujita E.Nagao Y.Seno K.Takao S.Miyasaka T.Kimura M.Watson WH. J. Chem. Soc., Perkin Trans. 1 1981, 914 - 67b
Nagao Y.Kawabata K.Seno K.Fujita E. J. Chem. Soc., Perkin Trans. 1 1980, 2470 - 68
El-Faham A.Chebbo M.Abdul-Ghani M.Younes G.
J. Heterocycl. Chem. 2006, 43: 1 - 69a
del Frenso M.El-Faham A.Carpino LA.Royo M.Albericio F. Org. Lett. 2000, 2: 3539 - 69b
Albericio F.Bofill JM.El-Faham A.Kates SA. J. Org. Chem. 1998, 63: 9678 - 69c
Gausepohl H.Pieles U.Frank RW. In Peptides: Chemistry and Biology, Proceedings of the 12th American Peptide SymposiumSmith JA.Rivier JE. ESCOM; Leiden / The Netherlands: 1992. p.523 - 70
Abdul-Ghani M.Khattab SN.El-Massry AM.El-Faham A.Amer A. Org. Prep. Proced. Int. 2004, 36: 121 - 71
Douglas EW.Hamilton S. J. Org. Chem. 2002, 67: 7553 - 72
Shik Y.Choi IS. Langmuir 2006, 22: 6956 - 73
Ulman A. Chem. Rev. 1996, 96: 1533 - 74a
Love JC.Estroff LA.Kriebel JK.Nuzzo RG.Whitesides GM. Chem. Rev. 2005, 105: 361 - 74b
Chi YS.Lee JK.Lee KB.Kim DJ.Choi IS. Bull. Korean Chem. Soc. 2005, 26: 361 - 75
Sullivan TP.Huck WTS. Eur. J. Org. Chem. 2003, 17 - 76
Chechik V.Crooks RM.Stirling CJM. Adv. Mater. 2000, 12: 1161 - 77a
Houseman BT.Mrksich M. Angew. Chem. Int. Ed. 1999, 38: 782 - 77b
Templeton AC.Hosteler MJ.Kraft CT.Murray RW. J. Am. Chem. Soc. 1998, 120: 1906 - 77c
Van Ryswyk H.Turtle ED.Watson-Clark R.Tanzer TA.Herman TK.Chong PY.Waller PJ.Taurog AL.Wagner CE. Langmuir 1996, 12: 6143 - 78a
Shimazu K.Teranishi T.Sugihara K.Uosaki K. Chem. Lett. 1998, 669 - 78b
Lee TR.Carey RI.Biebuyck HA.Whitesides GM. Langmuir 1994, 10: 741 - 78c
Bryant MA.Crooks RM. Langmuir 1993, 9: 385 - 79a
Yousaf MN.Chan EWL.Mrksich M. Angew. Chem. Int. Ed. 2000, 39: 1943 - 79b
Gawalt ES.Choi IS.Mrksich M. J. Am. Chem. Soc. 2004, 126: 15613 - 80
Chi YS.Choi IS. Langmuir 2005, 21: 11765 - 81
Olah GA.Nojima M.Kerekes I. Synthesis 1973, 487 - 82
Yan L.Marzolin C.Terfort A.Whitesides GM. Langmuir 1997, 13: 6704 - 83a
Chapman RG.Ostuni E.Yan L.Whitesides GM. Langmuir 2000, 16: 6927 - 83b
Yan L.Huck WTS.Zhao XM.Whitesides GM. Langmuir 1999, 15: 1208 - 83c
Chapman RG.Ostuni E.Liang MN.Meluleni G.Kim E.Yan L.Pier G.Warren S.Whitesides GM. Langmuir 2001, 17: 1225 - 83d
Lee KB.Kim DJ.Yoon KR.Kim Y.Choi IS. Korean J. Chem. Eng. 2003, 20: 956 - 83e
Chi YS.Choi IS. Adv. Funct. Mater. 2006, 16: 1031 - 84a
Nicolaou KC.Mitchell HJ.Suzuki H.Rodríguez RM.Baudoin O.Fylaktakidou KC. Angew. Chem. Int. Ed. 1999, 38: 3334 - 84b
Nicolaou KC.Mitchell HJ.Fylaktakidou KC.Rodríguez RM.Suzuki H. Chem. Eur. J. 2000, 6: 3116 - 85a
Ganguly AK.Pramanik B.Chan TC.Sarre O.Liu YT.Morton J.Girijavallabhan VM. Heterocycles 1989, 28: 83 - 85b
Ganguly AK. In Topics in Antibiotic Chemistry Vol. 2, Part B:Sammes PG. Wiley; New York: 1979. p.61-96 - 85c
Ganguly AK,Girijavallabhan VM,Sarre O, and . inventors; WO 87/02366. - 85d
Mahesh P,Gullo VP,Roberta H,Loebenberg D,Morton JB,Miller GH,Kwon HY, and . inventors; EP 0538011A1. - 85e
Ganguly AK.McCormick JL.Jinping LA.Saksena K.Das PR.Pradip R.Chan TM. Bioorg. Med. Chem. Lett. 1999, 9: 1209 - 86
Wright DE. Tetrahedron 1979, 35: 1207 - 87a
Ganguly AK.McCormick JL.Chan TM.Saksena AK.Das PR. Tetrahedron Lett. 1997, 38: 7989 - 87b
Chan TM.Osterman RM.Morton JB.Ganguly AK. Magn. Reson. Chem. 1997, 35: 529 - 88
Nicolaou KC.Rodríguez RM.Mitchell HJ.van Delft FL. Angew. Chem. Int. Ed. 1998, 37: 1874 ; Angew. Chem. 1998, 110, 1975 - 89
Ritzén A.Frejd T. Eur. J. Org. Chem. 2000, 3771 - 90
Nicolaou KC.Rodríguez RM.Fylaktakidou KC.Suzuki H.Mitchell HJ. Angew. Chem. Int. Ed. 1999, 38: 3340 - 91a
Newkome GR.Moorefield CN.Dendric VF. Molecules, Concepts, Synthesis, Perspectives VCH Publishers; Weinheim: 1996. - 91b
Engel R. In Advances in Dendritic Macromolecules Vol. 2:Newkome GR. JAI Press; Stamford: 1995. p.73 - 92
Fischer M.Vogtle F. Angew. Chem. Int. Ed. 1999, 38: 884
References

Figure 1 Structures of chlorinating reagents

Figure 2

Scheme 1

Scheme 2 Synthesis of amino acid fluorides using cyanuric fluoride

Scheme 3 Synthesis of amino acid fluorides using TFFH

Figure 3 Structures of fluorinating reagents

Figure 4

Figure 5

Figure 6

Scheme 4 Synthesis of TFFH

Figure 7 Small phosphotyrosine-containing peptides

Scheme 5 Synthesis of l-lysine analogues: (a) ROH/H+; (b) Z-OSu, Et3N; (c) BzlBr, Et3N, acetone; (d) Tf2O, lutidine, CH2Cl2; (e) nucleophile, Et3N; (f) TFFH (1.2 equiv), DIPEA (2 equiv) CH2Cl2.

Scheme 6 Preparation of pseudotripeptides: (a) Z-OSu, Et3N; (b) WSC (water soluble carbodiimide, 1.5 equiv), DIPEA (3 equiv), HOBt (1 equiv), ProOBut (1.2 equiv); (c) Tf2O, lutidine, -78 ˚C; (d) H2NOBn (5 equiv); (e) NH2CH2CH=CH2, Et3N (4 equiv); (f) TFFH (1.2 equiv), DIPEA (2 equiv), CH2Cl2.

Scheme 7 Synthesis of tetrapeptidyl methylcoumarin esters

Scheme 8 Synthesis of a cyclized dipeptide

Scheme 9 C-Terminal active ester conjugation of fullerene C60 or C70 in solution to [Phe20]alamethicin F30-2-aminoethyl amide synthesized on 2-chlorotrityl resin using in situ TFFH activation; (a) cleavage (hexafluoro-2-propanol-dichloromethane, 1 h); (b) coupling of the fullerene succinimide ester (CH2Cl2, 4 h), precipitation, and flash chromatography on silica gel; (c) deprotection [TFA-CH2Cl2 (1:1) containing 5% H2O and 2% i-Pr3SiH].

Scheme 10 N-Terminal conjugation of fullerene(60)-carboxylic acid to [Ac21]alamethicin F30 synthesized on 2-chlorotrityl resin using TFFH activation; (a) cleavage and deprotection [TFA-CH2Cl2 (1:1) containing 5% H2O and 2% i-Pr3SiH]; (b) after purification (RP-HPLC), conjugation in solution with fullerene(60)-carboxylic acid (preactivation with HATU, DIPEA, bromobenzene-DMF, 15 h).

Scheme 11 Synthesis of isothiocyanates, imidazolidine-2-thiones, and hydrazides using TFFH

Scheme 12 Synthesis of N,N′-diacylhydrazides and acyl azides using TFFH

Scheme 13 Activation of carboxylic acids by means of TFFH

Figure 8

Scheme 14 Synthesis of esters, thioesters, and thioacids using TFFH

Figure 9 Esters synthesized using TFFH as fluorinating agent

Scheme 15 Chemoselective N-acylation of thiazolidine-2-thione using TFFH

Figure 10 Examples of thioesters and N-acylthiazolidine-2-thiones synthesized using TFFH as fluorinating agent

Scheme 16 Synthesis of alcohols and hydroxamic acids using TFFH/PTF

Scheme 17 Synthesis of 1,1,3,3-tetrasubstituted 4-aminoguanidines and [1,2,4]triazolo derivatives using TFFH

Scheme 18 Synthesis of azole derivatives using TFFH

Figure 11 Everninomicin 13,384-1 (74)

Figure 12 Structure of the A1B(A)C fragment 75

Figure 13 Structure of the FGHA2 fragment 77

Scheme 19 Proposed mechanism for the formation of interchain carboxylic anhydride

Scheme 20 Synthesis of acyl fluoride 76 using TFFH

Scheme 21 Synthesis of chiral polyionic G2A dendrimer 84

Scheme 22 Synthesis of chiral polyionic G2B dendrimer 85

Figure 14

Figure 15